Comments
On Thursday, 11 March, Norway, Denmark and some other European countries suspended the use of the Oxford-AstraZeneca COVID vaccine post reports of blood clotting in some vaccine recipients. There were also reports that a 50-year-old man had died in Italy after developing deep vein thrombosis (DVT) following a dose of the jab.
However, the EU's medicines regulator said that there is no indication that the vaccine is linked to an increased risk of blood clots, reported
IANS. It said the number of cases in vaccinated people was no higher than in the general population.
“There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine. The vaccine’s benefits continue to outweigh its risks and the vaccine can continue to be administered while investigation of cases of thromboembolic events is ongoing,”European Medicines Agency (EMA) said on Thursday, 11 March.